Position in EOLS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,707,650
-$3,520,779 QoQ
Shares Held
822,428
-63.4% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#17
of 157 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $361,941,334 across 8 Drug Manufacturers - Specialty & Generic names. EOLS ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
225,587 | $122,229,804 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
867,760 | $71,833,172 | |
| 3 | ALKS |
Alkermes plc.
|
1,029,252 | $53,932,804 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,064,000 | $43,655,920 | |
| 5 | ORGO |
Organogenesis Holdings Inc.
|
10,140,951 | $24,642,510 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
520,000 | $24,185,200 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
246,353 | $15,754,274 | |
| 8 | EOLS |
Evolus, Inc.
This page
|
822,428 | $5,707,650 |
All Filings in EOLS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,707,650 | 822,428 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,228,429 | 2,245,360 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,115,500 | 1,070,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,903,000 | 1,450,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,515,990 | 2,119,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $12,982,270 | 1,079,158 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,696,624 | 697,158 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,810,416 | 1,037,680 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,499,200 | 1,152,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,240,000 | 160,000 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $18,992,920 | 2,078,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,393,590 | 1,017,000 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $9,403,841 | 810,676 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,353,324 | 1,368,389 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,195,367 | 1,258,889 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,899,157 | 642,934 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,337,000 | 580,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||